Phenotypic, genotypic, and functional characterization of normal and acute myeloid leukemia-derived marrow endothelial cells.
暂无分享,去创建一个
M. Azadniv | J. Liesveld | M. Coppage | Joshua A. Acklin | N. Guo | Russell J Pizzo | Kimberly Lacagnina | Russell J. Pizzo | Russell J. Pizzoa | Mitra Azadniva | Naxin Guoa | Joshua Acklina | Kimberly Lacagninaa | Myra Coppageb | Jane L. Liesvelda | Jane L. Liesveld | Russell J. Pizzo | Naxin Guo | Joshua Acklin | Myra Coppage
[1] S. Leem,et al. Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia. , 2015, Cancer research.
[2] S. Rafii,et al. Activation of the vascular niche supports leukemic progression and resistance to chemotherapy. , 2014, Experimental hematology.
[3] D. Scadden,et al. Cellular thrust and parry in the leukemic niche. , 2014, Blood.
[4] B. Leber,et al. Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs , 2014, The Journal of experimental medicine.
[5] T. Enver,et al. Leukemia propagating cells rebuild an evolving niche in response to therapy. , 2014, Cancer cell.
[6] R. Davis,et al. Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance. , 2014, Blood.
[7] E. Scott,et al. Functional Integration of Acute Myeloid Leukemia into the Vascular Niche , 2014, Leukemia.
[8] J. Lorens,et al. In Vitro Characterization of Valproic Acid, ATRA, and Cytarabine Used for Disease-Stabilization in Human Acute Myeloid Leukemia: Antiproliferative Effects of Drugs on Endothelial and Osteoblastic Cells and Altered Release of Angioregulatory Mediators by Endothelial Cells , 2014, Leukemia research and treatment.
[9] F. Marincola,et al. Leukemia cells induce changes in human bone marrow stromal cells , 2013, Journal of Translational Medicine.
[10] A. Arbab,et al. Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K/BxN serum-induced arthritis. , 2013, Arthritis and rheumatism.
[11] M. Kuroda,et al. Leukemia cell to endothelial cell communication via exosomal miRNAs , 2013, Oncogene.
[12] Ø. Bruserud,et al. Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells , 2013 .
[13] Ø. Bruserud,et al. Pharmacological targeting of the PI3K/mTOR pathway alters the release of angioregulatory mediators both from primary human acute myeloid leukemia cells and their neighboring stromal cells , 2013, Oncotarget.
[14] H. Urlaub,et al. β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis. , 2013, Blood.
[15] G. Madlambayan,et al. Leukemia Mediated Endothelial Cell Activation Modulates Leukemia Cell Susceptibility to Chemotherapy through a Positive Feedback Loop Mechanism , 2013, PloS one.
[16] N. Heisterkamp,et al. Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy. , 2013, Blood.
[17] Jingru Zhang,et al. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway. , 2013, Carcinogenesis.
[18] David G Hendrickson,et al. Differential analysis of gene regulation at transcript resolution with RNA-seq , 2012, Nature Biotechnology.
[19] T. Suda,et al. Two anatomically distinct niches regulate stem cell activity. , 2012, Blood.
[20] A. Reinisch,et al. Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment. , 2012, Blood.
[21] S. Rafii,et al. Serial monitoring of human systemic and xenograft models of leukemia using a novel vascular disrupting agent , 2012, Leukemia.
[22] A. Zarbock,et al. Leukocyte integrin activation and deactivation: novel mechanisms of balancing inflammation , 2011, Journal of Molecular Medicine.
[23] Ulrich Keilholz,et al. Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts. , 2011, Blood.
[24] C. Cogle,et al. Angiogenesis in Acute Myeloid Leukemia and Opportunities for Novel Therapies , 2011, Journal of oncology.
[25] F. Gao,et al. CD44 mediates oligosaccharides of hyaluronan-induced proliferation, tube formation and signal transduction in endothelial cells , 2011, Experimental biology and medicine.
[26] E. Scott,et al. Leukemia regression by vascular disruption and antiangiogenic therapy. , 2010, Blood.
[27] Ø. Bruserud,et al. Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release , 2010, Expert opinion on investigational drugs.
[28] D. Ribatti,et al. Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma , 2009, Clinical Cancer Research.
[29] D. Scadden,et al. The leukemic stem cell niche: current concepts and therapeutic opportunities. , 2009, Blood.
[30] E. Estey,et al. Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. , 2009, Blood.
[31] Sören Lehmann,et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. , 2009, Blood.
[32] Ø. Bruserud,et al. Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators , 2009, British journal of haematology.
[33] Angela C. Colmone,et al. Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells , 2008, Science.
[34] Ø. Bruserud,et al. Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels , 2008, Leukemia.
[35] J. Liesveld,et al. Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells. , 2007, Leukemia research.
[36] K. Parmar,et al. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia , 2007, Proceedings of the National Academy of Sciences.
[37] W. Berdel,et al. Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity , 2007, Leukemia.
[38] W. Berdel,et al. Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia. , 2006, Haematologica.
[39] S. Sallan,et al. Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival. , 2006, Experimental hematology.
[40] J. Lancet,et al. Acute myelogenous leukemia—microenvironment interactions: Role of endothelial cells and proteasome inhibition , 2005, Hematology.
[41] P. Smolewski,et al. Circulating endothelial cells in patients with acute myeloid leukemia , 2005, European journal of haematology.
[42] Dan Mercola,et al. Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. , 2005, Cancer research.
[43] Ø. Bruserud,et al. Coculture of native human acute myelogenous leukemia blasts with fibroblasts and osteoblasts results in an increase of vascular endothelial growth factor levels , 2005, European journal of haematology.
[44] F. Appelbaum,et al. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5). , 2001, Experimental hematology.
[45] M. Schapira,et al. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. , 2001, Blood.
[46] S. Rafii,et al. Regulation of hematopoiesis by microvascular endothelium. , 1997, Leukemia & lymphoma.
[47] S. Ergün,et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. , 1997, Blood.
[48] B. Zetter,et al. In situ labelling of vascular endothelium with fluorescent acetylated low density lipoprotein , 1985, The Histochemical Journal.
[49] T. Suda,et al. EFFECT OF HYDROCORTISONE ON LONG‐TERM HUMAN MARROW CULTURES , 1981, British journal of haematology.
[50] E. Edelman,et al. Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-kappaB. , 2006, Blood.
[51] George M. Rodgers,et al. Evidence of increased angiogenesis in patients with acute myeloid leukemia. , 2000, Blood.
[52] M. Adolphe,et al. A non-isotopic, highly sensitive, fluorimetric, cell-cell adhesion microplate assay using calcein AM-labeled lymphocytes. , 1995, Journal of immunological methods.
[53] S. Rafii,et al. Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. , 1994, Blood.